Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Manual Therapy
|
October 4, 2016
Scapular dyskinesis: Patterns, functional disability and associated factors in people with shoulder disorders
Tsun-Shun Huang, Chien-Ying Huang, Hsiang-Ling Ou, et al.
Journal of Shoulder and Elbow Surgery
|
February 24, 2015
Specific kinematics and associated muscle activation in individuals with scapular dyskinesis
Tsun-Shun Huang, Hsiang-Ling Ou, Chien-Ying Huang, et al.
Biomedicines
|
July 29, 2023
The Beneficial Role of Photobiomodulation in Neurodegenerative Diseases
Ayodeji Abijo, Chun-Yuan Lee, Chien-Ying Huang, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
September 14, 2019
Angiotensin Receptor Neprilysin Inhibitor for Patients With Heart Failure and Reduced Ejection Fraction: Real-World Experience From Taiwan
Fu-Chih Hsiao, Chun-Li Wang, Po-Cheng Chang, et al.
Diabetes, Obesity & Metabolism
|
May 28, 2021
Impact of the initial decline in estimated glomerular filtration rate on the risk of new-onset atrial fibrillation and adverse cardiovascular and renal events in patients with type 2 diabetes treated with sodium-glucose co-transporter-2 inhibitors
Yi-Hsin Chan, Shao-Wei Chen, Tze-Fan Chao, et al.
Cardiovascular Diabetology
|
May 4, 2021
The impact of weight loss related to risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitor
Yi-Hsin Chan, Shao-Wei Chen, Tze-Fan Chao, et al.
Cardiovascular Diabetology
|
August 17, 2021
The risk of consequent nephropathy following initial weight loss in diabetic patients treated with sodium glucose cotransporter 2 inhibitors
Yi-Hsin Chan, Shao-Wei Chen, Tze-Fan Chao, et al.
ESC Heart Failure
|
July 7, 2020
Sodium glucose cotransporter-2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function
Yi-Hsin Chan, Tzyy-Jer Hsu, Chun-Li Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 31, 2023
The Association of Background Medications on Initial eGFR Change and Kidney Outcomes in Diabetic Patients Receiving SGLT2 Inhibitor
Yi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
July 7, 2022
Association of acute increases in serum creatinine with subsequent outcomes in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 inhibitor
Yi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Manual Therapy
|
October 4, 2016
Scapular dyskinesis: Patterns, functional disability and associated factors in people with shoulder disorders
Tsun-Shun Huang, Chien-Ying Huang, Hsiang-Ling Ou, et al.
Journal of Shoulder and Elbow Surgery
|
February 24, 2015
Specific kinematics and associated muscle activation in individuals with scapular dyskinesis
Tsun-Shun Huang, Hsiang-Ling Ou, Chien-Ying Huang, et al.
Biomedicines
|
July 29, 2023
The Beneficial Role of Photobiomodulation in Neurodegenerative Diseases
Ayodeji Abijo, Chun-Yuan Lee, Chien-Ying Huang, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
September 14, 2019
Angiotensin Receptor Neprilysin Inhibitor for Patients With Heart Failure and Reduced Ejection Fraction: Real-World Experience From Taiwan
Fu-Chih Hsiao, Chun-Li Wang, Po-Cheng Chang, et al.
Diabetes, Obesity & Metabolism
|
May 28, 2021
Impact of the initial decline in estimated glomerular filtration rate on the risk of new-onset atrial fibrillation and adverse cardiovascular and renal events in patients with type 2 diabetes treated with sodium-glucose co-transporter-2 inhibitors
Yi-Hsin Chan, Shao-Wei Chen, Tze-Fan Chao, et al.
Cardiovascular Diabetology
|
May 4, 2021
The impact of weight loss related to risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitor
Yi-Hsin Chan, Shao-Wei Chen, Tze-Fan Chao, et al.
Cardiovascular Diabetology
|
August 17, 2021
The risk of consequent nephropathy following initial weight loss in diabetic patients treated with sodium glucose cotransporter 2 inhibitors
Yi-Hsin Chan, Shao-Wei Chen, Tze-Fan Chao, et al.
ESC Heart Failure
|
July 7, 2020
Sodium glucose cotransporter-2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function
Yi-Hsin Chan, Tzyy-Jer Hsu, Chun-Li Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 31, 2023
The Association of Background Medications on Initial eGFR Change and Kidney Outcomes in Diabetic Patients Receiving SGLT2 Inhibitor
Yi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
July 7, 2022
Association of acute increases in serum creatinine with subsequent outcomes in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 inhibitor
Yi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, et al.
Page
of 2